Search Results for david shulkin

Breaking: Teladoc and Livongo close merger in $18.5 billion deal, staff/board changeovers

...CFO Lee Shapiro (widely conceded as the merger engineer), and SVP of business development Steve Schwartz. David Sides, Livongo’s COO, and Arnnon Geshuri, Cheif (sic) Human Resources Officer, retain their same position as at Teladoc. According to their latest (29 Oct) 8-K, new members of the board effective 19 November will include Glen Tullman (formerly Livongo Executive Chair), Chris Bischoff (Kinnevic AB), Karen L. Daniel, Sandra Fenwick, and Hemant Taneja (General Catalyst, of which more follows). MedCityNews detailed the above plus that R&D will be headed on an interim basis by Yulun Wang, PhD, who came over from InTouch. Also,... Continue Reading

‘Before the Ashes Fall’: the story behind the book and the movie in development about dementia

Editor’s Note: The author of the post below, David Serafine, is a corporate security professional in the US. He is not like most of our Readers, a professional in healthcare technology or social care. What compelled him to write a novel about a father and son, and a family affected by the onset of Alzheimer’s Disease, is his own family’s story. We deal with dementia as professionals, but it has also touched and affected our family lives, and in many cases, our work lives. David reached out to me through a post on LinkedIn and after some discussion, I have... Continue Reading

Reflections in a Gimlet Eye: further skeptical thoughts on the Teladoc acquisition of Livongo (updated)

...and health plan market, then expressed surprise at why Livongo agreed to be acquired: “The company had a real shot at becoming a $100 billion business by running the ‘digital hospital’ playbook. In some ways, the acquisition feels premature.” Teladoc’s COO David Sides promised that the combined company will aid practices in the transition from hospital to home care, touting the consumer focus of both companies. (Have they consulted already burdened and strained providers how this can be made easier for them and fit into value-based care models as well as their financials?) But they may have to make more... Continue Reading

Post-COVID back to work: for workplace screening, testing, contact tracing, there’s an app for that

...had contact with over the past X days via Bluetooth. As PWC’s David Sapin of their connected solutions area put it, “But if you’re going to come back into the workplace, you need to accept having this type of app on your phone.” For a really dystopian view, see this article in Bloomberg. You may be scanned thermally, have an elevator operator (back to the past!), and lots and lots of sensors monitoring your comings and goings. Facilities departments will be retrofitting for anti-microbial surfaces and plexiglass guards. Before you are allowed to return, if you are allowed to return,... Continue Reading

Mount Sinai Health Partners (NY) launches Babylon Health telehealth app

...The Forbes article starts off like a glossy Babylon press release, but continues on to some of Babylon’s recent and controversial press, such as Saudi Arabia’s Public Investment Fund (PIF) participating in the last $550 million investment round and the tart feedback of many UK doctors on how much ‘care’ can be pushed off onto apps like ‘GP At Hand’. Not mentioned is the controversy around the accuracy of the chatbots when it comes to giving advice, which was the subject of Newsnight and @DrMurphy11 (Dr. David Watkins), who has been raising performance issues for some time. [TTA 27 Feb]... Continue Reading

Babylon Health fires back at critic @DrMurphy11; Dr. Watkins–and Newsnight–return fire (UK)

...earlier this week to BBC Two’s Newsnight’s Emma Barnett on a profile of ‘healthcare juggernaut’ Babylon as Dr. David Watkins, a consultant oncologist. You can see him on YouTube here (at the 1 minute and 3 min. 30 mark). He demonstrates the response of the chatbot, using as the patient an older male smoker with chest pains. The chatbot advises him that he might have either gastritis or ‘sickle cell crisis in chest’–and to go to his GP in 6 hours. What is far more likely than sickle cell with this history is, of course, a heart attack, as a... Continue Reading

Comings and goings, short takes and upcoming events: MedStartr Wed night, Mad*Pow acquired, Teladoc’s new COO, JAMA ponders telepharmacy, NHS London anxiety apps partner (updated)

...of digital health employees on a variety of viewpoints where digital health can lower versus increase costs. Teladoc has a new COO, David Sides, who is joining from a CEO position at Streamline Health, a revenue cycle management company. The previous COO/CFO left after investors alleged insider trading and an inappropriate employee affair. Cited in Modern Healthcare is Mr. Sides’ experience in international markets, where Teladoc has been expanding through acquisitions. Teladoc announced today increased revenue for 2nd Q but earnings are still in the loss column. Yahoo Finance His position at Streamline is being taken by their chairman, Wyche... Continue Reading

The GreatCall Lively Mobile Plus Federal District Court lawsuit–and TTA

...what a letter from their CEO David Inns described as an “important safety recall,” offering buyers a Jitterbug flip phone or a full refund. The link above was to a fairly comprehensive 3 June article in Mobihealthnews on a Federal District Court-Central District of California class action lawsuit filed by firm Bisnar Chase on 22 May on behalf of plaintiff Scott Barnes of San Luis Obispo, California (document via Mobihealthnews). Mr. Barnes purchased the device on 21 April. In early May, Mr. Barnes fell twice but the device did not detect the fall and automatically alert emergency services. Mr. Barnes... Continue Reading

News roundup: Phreesia’s IPO, Chiptech enters UK telecare market, PatientsLikeMe goes to UHG, Medopad-Tencent UK Parkinson’s pilot, Oxford VR goes to HK, Cigna Singapore’s telehealth intro, HIMSS exiting Cleveland

...Roberts, Michael Weintraub). Their business includes 1,600 health firms and 70 million patient intakes annually, for $100 million in revenue in its last fiscal year, up 25 percent from previous. Timing of the IPO is not yet forecast. Mobihealthnews, Business Insider. Coming to the UK and Europe markets are New Zealand’s Chiptech telecare systems. Chiptech has both traditional in-home and mobile monitored PERS, pill dispensers, and a smartphone-based lone worker alert device. According to their website, they are the leading provider of monitored personal alarms in Australasia. Chiptech also announced a new CEO, veteran David Hammond, whose background includes leadership... Continue Reading